Mutz Christopher 4
4 · ANI PHARMACEUTICALS INC · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Mutz Christopher
HEAD OF RARE DISEASE
Transactions
- Sale
Common Stock
[F1]2026-03-02$74.00/sh−417$30,858→ 103,508 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.
Signature
/s/ Christopher Mutz, by attorney-in-fact Meredith W. Cook|2026-03-04